ePHex : a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria

Gema Ariceta Iraola, L. Collard, S. Abroug, S.H. Moochhala, E. Gould, A. Boussetta, M. Ben Hmida, S. De, T.E. Hunley, F. Jarraya, Gloria M. Fraga, A. Banos, E. Lindner, B. Dehmel, G. Schalk

Research output: Contribution to journal › Article › Research › peer-review

15   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'ePHex : a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science